CoChat

Statins and renovascular disease in the elderly: a population-based cohort study

Open access
Hackam, D. G., Wu, F., Li, P., Austin, P. C., Tobe, S. W., Mamdani, M. M., Garg, A. X. · 2011 · European Heart Journal

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

AIMS: More than 90% of cases of renovascular disease (RVD) are caused by atherosclerosis; thus patients with this condition are at high risk for vascular events. We examined the association of statins with prognosis in patients with RVD. METHODS AND RESULTS: We performed a population-based cohort study in 4040 patients with RVD older than 65 years using province-wide health data in Ontario, Canada. The primary outcome was time to first cardiorenal event, specifically myocardial infarction, stroke, heart failure, acute renal failure, dialysis or death; the primary analysis used a time-dependent covariate for statin exposure. Despite having a greater burden of cardiovascular and renal comorbidity, the risk of the primary outcome was significantly lower in statin users than in non-users [unadjusted hazard ratio (HR) 0.51, 95% confidence interval (CI) 0.47-0.57; P < 0.0001]. This association was materially unchanged after adjusting for demographic characteristics, cardiovascular risk factors, other comorbidities, measures of health-care utilization, screening, and concomitant medications (adjusted HR 0.51, 95% CI 0.46-0.57). An analysis using the same endpoint in a propensity-matched cohort without time-dependent statin exposure revealed a lower risk of the primary outcome in statin-treated patients but with a substantially more conservative point estimate (HR 0.82, 95% CI 0.71-0.95). CONCLUSION: These data suggest that statins are associated with improved prognosis in elderly patients with RVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehq452

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 1

  1. Levy, 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 10, 67

Cited by

See all 49

Metadata

Authors
Hackam, D. G., Wu, F., Li, P., Austin, P. C., Tobe, S. W., Mamdani, M. M., & Garg, A. X.
Affiliations
  • Western University (CA)
  • University of Toronto (CA)
  • St. Michael's Hospital (CA)
Corresponding author
Hackam, D. G.
Venue
European Heart Journal
Published
2010-12-14
Volume
32
Issue
5
Pages
598-610
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2081426235
Cited by
49
References
29
Citations by year
2025: 2 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 1
FWCI
2.03
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • Physicians' Services Incorporated Foundation
  • Canadian Institutes of Health Research (104702)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Nephrology › Renal and Vascular Pathologies
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
Keywords
statins, renovascular disease, elderly patients, atherosclerosis, cardiovascular risk, renal outcomes, time-varying covariates, propensity score matching, prognosis
MeSH terms
Aged, Female, Heart Failure, Renal Dialysis, Humans, Kidney Failure, Chronic, Male, Myocardial Infarction, Ontario, Prognosis, Retrospective Studies, Risk Factors, Survival Analysis, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statins and renovascular disease in the elderly: a population-based cohort study. https://app.cochat.ai/papers/10.1093/eurheartj/ehq452
The paper
Hackam, D. G., Wu, F., Li, P., Austin, P. C., Tobe, S. W., Mamdani, M. M., & Garg, A. X. (2011). Statins and renovascular disease in the elderly: a population-based cohort study. European Heart Journal. https://doi.org/10.1093/eurheartj/ehq452

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.